Fewer administration fees and a decreased profit from the Pediarix vaccine itself were the most common reasons for decreased revenue (69% and 51%, respectively), and 74 practices had raised or planned to raise fees to recoup their losses.
Some practices simply charged more for the vaccine—23% of practices charged payers more for the vaccine, while 12% charged patients more for it. In addition, 16% of practices charged payers higher administration fees, 9% charged patients higher administration fees, 7% charged payers more for office visits, and 3% charged patients more for office visits.
Nice. Because they aren't making as much money on the combo vaccine, some practices are charging everyone more money for office visits. Some practices won't order it because they lose money, but vaccines aren't about money.
Have to save this one for those who say it can't be about the money.
Be careful using this article - it actually says that the combo vax doesn't hurt profits - only 11% of peds polled said that it did. The other 89% said it didn't hurt practice profits. Although, that could be because they raised their price.